COI Pharmaceuticals

@COIPharma

Avalon Ventures' Community Of Innovation (COI) offers life science experts an environment where entrepreneurial and scientific risks are encouraged and rewarded

Vrijeme pridruživanja: listopad 2015.

Tweetovi

Blokirali ste korisnika/cu @COIPharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @COIPharma

  1. proslijedio/la je Tweet
    22. sij

    New speakers just added: Jay Lichter of / Kim Kamdar () of Domain Associates Kyle Gano of Neurocrine of

    Poništi
  2. 21. sij

    Looking forward to Thursday's panel discussion at COI's president and CEO, Jay Lichter, will be sharing his experiences serving on boards

    Poništi
  3. 1. sij

    Happy New Year from the COI team and cheers to another great year ahead!

    Poništi
  4. 24. pro 2019.

    We have so much to celebrate this season. A big thank you to our clients and our supporters – we wish you all the best for the holiday and new year!

    Poništi
  5. 9. pro 2019.
    Poništi
  6. 14. stu 2019.

    New from : Jay Lichter shares how pursuing science breakthroughs while mentoring new startups has helped build a strong pipeline in :

    Poništi
  7. 12. stu 2019.

    COI announces the acquisition of Calporta by Merck for TRPML1 agonists that could treat lysosomal storage and neurodegenerative diseases.

    Poništi
  8. 10. ruj 2019.

    Sitari, the first company formed under the GSK-Avalon venture collaboration and incubated at COI, has been acquired by . GSK will obtain Sitari’s transglutaminase 2 small molecule program for

    Poništi
  9. 7. sij 2019.

    Good morning from ! COI’s President and CEO Jay Lichter talks with about

    Poništi
  10. 2. sij 2019.

    It’s been a great year for COI startups! Check out these company milestones, funding successes, honors and more

    Poništi
  11. 2. sij 2019.

    Cheers from the COI team! May your new year be filled with and life-improving !

    Poništi
  12. 24. pro 2018.

    COI hopes you and your loved ones have a very happy holiday!

    Poništi
  13. 14. stu 2018.

    Our portfolio company has filed a $100 million IPO. Read more from And here's more background from their May financing:

    Poništi
  14. 6. stu 2018.

    COI portfolio company Fortis Therapeutics has been awarded two investigational new drug (IND) applications for its lead candidate, FOR46, in metastatic castration-resistant prostate cancer and late-stage multiple myeloma.

    Poništi
  15. 18. lis 2018.

    That's a wrap on another successful Tour de COI. Thanks to all our awesome colleagues who participated in this year's event.

    Poništi
  16. 15. lis 2018.

    Hunting for a memorable name for your life science startup? Here are some tips on what to consider and what to avoid.

    Poništi
  17. 3. lis 2018.

    Congrats to COI portfolio company for making the list of “highest-rated companies for work-life balance in 2018.” AristaMD made the top 10 for small to mid-sized co.’s and was the only SoCal co. on the list.

    Poništi
  18. 6. ruj 2018.

    Fran Senchak, COI's VP of Human Resources and Administration, talks about asking for constructive criticism and how that can help further your career in this month’s feature article

    Poništi
  19. 2. srp 2018.

    The new edition of is out - be sure to snag a copy or go online to learn more about how the COI community strives to turn dynamic scientific research into breakthroughs.

    Poništi
  20. proslijedio/la je Tweet
    27. lip 2018.

    Excellent podcast - explains the founding of in a super interesting interview with our founder !

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·